Sentences with phrase «based on breast cancer»

Not exact matches

Your chances of surviving cardiac arrest — which can strike in healthy people, and kills more Americans each year than Alzheimer's, breast cancer, cervical cancer, colorectal cancer, diabetes, HIV, car crashes, prostate cancer, and suicides combined — vary immensely based on your zip code.

Large says a portion of the proceeds from the Diva brand is being donated to breast cancer charities on a state - by - state basis according to local distributors.

Melanie Young (New York, NY)-- Chief Connector and Creative Strategist at The Connected Table, a New York - based public relations and events business, Melanie is a speaker and author of Melanie Young — Getting Things Off My Chest: A Survivor's Guide to Staying Fearless and Fabulous in the Face of Breast Cancer, which provides tips for women on how to manage their diagnosis and stay focused and in charge of their health.

An excellent book on this subject is «Dressed to Kill: The link between breast cancer and bras» http://astore.amazon.com/peacefparent-20/detail/1930858051 There is certainly ample research today on the lymphatic system to suggest that constricting it on a daily basis is not a good idea...

Your breast cancer care team works closely with you to create a personalized treatment plan based on your particular situation, as well as your needs and goals.

PRIMAVERA, a pioneering, German - based line of natural and organic skincare and aromatherapy, will commemorate Breast Cancer Awareness Month with a donation based on product sales to the organization Look Good... Feel Better.

Nearly a fifth (17 %) of women who have been diagnosed with breast cancer after spotting a potential symptom wait over a month before seeing their GP, equating to an estimated 6,000 women every year in the UK, according to calculations based on new YouGov figures released today from Breast Cancerbreast cancer after spotting a potential symptom wait over a month before seeing their GP, equating to an estimated 6,000 women every year in the UK, according to calculations based on new YouGov figures released today from Breast Cancercancer after spotting a potential symptom wait over a month before seeing their GP, equating to an estimated 6,000 women every year in the UK, according to calculations based on new YouGov figures released today from Breast CancerBreast CancerCancer Care.

Besides working at IBM's Thomas J. Watson Research Center in Yorktown Heights, New York, Meyer heads something called the DREAM challenges, contests that ask teams of computer scientists to solve outstanding biomedical problems, such as predicting the outcome of prostate cancer treatment based on clinical variables or detecting breast cancer from mammogram data.

Rottenberg hopes that in the future, based on these findings, the treatment of breast, ovarian and prostate cancer can be improved.

Researchers are even working to develop tests for breast cancer and organ transplant rejection based on the bouquet of a patient's breath.

(Breast cancer is categorized and treated based on the presence or absence of three hormone receptors displayed on the outer membranes of cells.

A scientist from the NIH was one author of the paper describing the discovery, but Myriad Pharmaceuticals, which signed an exclusive licence with the University of Utah where the rest of the research was done, doesn't seem interested in sharing the profits if a breast cancer screening test is devised based on the discovery.

When breast cancer is diagnosed, the drug regimen that the patient receives is based primarily on the results of a biopsy that is used to identify the type of tumor she has.

Professor Doug Easton from the University of Cambridge, one of the lead investigators on the study, says: «These findings add significantly to our understanding of the inherited basis of breast cancer.

Dr. Sparano continued: «This is the first prospectively conducted clinical trial evaluating this assay — or any multigene expression assay for that matter — in which patients with early stage breast cancer were uniformly treated based on their assay results.

To ensure access to mammography, Congress delayed for two years any changes to insurance coverage based on these recommendations, while breast cancer experts vet the recommendations and the process by which they were created.

The resulting «map» of gene - drug interactions allowed the researchers to accurately predict the responses of multiple human cancer cell lines to different chemotherapy agents based on the cell lines» genetic profiles and also revealed new genetic factors that appear to determine the response of breast and ovarian tumor cells to common classes of chemotherapy treatment.

Gerry Potter and Ray McCague of the Institute of Cancer Research in Surrey based their design strategy on tamoxifen, a drug widely used for treating breast cCancer Research in Surrey based their design strategy on tamoxifen, a drug widely used for treating breast cancercancer.

«Randomized Controlled Pilot Trial of Mindfulness - based Stress Reduction for Breast and Colorectal Cancer Survivors: Effects on Cancer - related Cognitive Impairment,» published online in advance of print in the Journal of Cancer Survivorship, is the first randomized clinical trial to evaluate the effects of mindfulness - based stress reduction, known as MBSR, on fatigued breast and colorectal cancer survivors, the majority of whom had been treated with chemothBreast and Colorectal Cancer Survivors: Effects on Cancer - related Cognitive Impairment,» published online in advance of print in the Journal of Cancer Survivorship, is the first randomized clinical trial to evaluate the effects of mindfulness - based stress reduction, known as MBSR, on fatigued breast and colorectal cancer survivors, the majority of whom had been treated with chemothCancer Survivors: Effects on Cancer - related Cognitive Impairment,» published online in advance of print in the Journal of Cancer Survivorship, is the first randomized clinical trial to evaluate the effects of mindfulness - based stress reduction, known as MBSR, on fatigued breast and colorectal cancer survivors, the majority of whom had been treated with chemothCancer - related Cognitive Impairment,» published online in advance of print in the Journal of Cancer Survivorship, is the first randomized clinical trial to evaluate the effects of mindfulness - based stress reduction, known as MBSR, on fatigued breast and colorectal cancer survivors, the majority of whom had been treated with chemothCancer Survivorship, is the first randomized clinical trial to evaluate the effects of mindfulness - based stress reduction, known as MBSR, on fatigued breast and colorectal cancer survivors, the majority of whom had been treated with chemothbreast and colorectal cancer survivors, the majority of whom had been treated with chemothcancer survivors, the majority of whom had been treated with chemotherapy.

Used in conjunction with mammography, imaging based on nuclear medicine is currently being used as a successful secondary screening alongside mammography to reduce the number of false positive results in women with dense breasts and at higher risk for developing breast cancer.

Since diet can influence insulin activation, the researchers wondered whether diet could impact breast cancer prognosis based on expression of the IGF1 receptor in the primary breast tumor tissue.

This is the first study to suggest that it might be possible to personalize recommended diets for breast cancer survivors based on the molecular characteristics of their primary tumor.

Further research is needed to confirm these findings, and Emond notes that breast cancer survivors should not be concerned about dramatically lowering their carbohydrate intake based on this study.

Based on these results, two phase 3 trials are being planned for platinum - sensitive and platinum - resistant ovarian cancer patients by one of NCI's new National Cancer Trial Network Groups, the NRG Oncology Group (formerly 3 cooperative groups: the National Surgical Adjuvant Breast and Bowel Project (NSABP), the Radiation Therapy Oncology Group (RTOG), and the Gynecologic Oncology Group cancer patients by one of NCI's new National Cancer Trial Network Groups, the NRG Oncology Group (formerly 3 cooperative groups: the National Surgical Adjuvant Breast and Bowel Project (NSABP), the Radiation Therapy Oncology Group (RTOG), and the Gynecologic Oncology Group Cancer Trial Network Groups, the NRG Oncology Group (formerly 3 cooperative groups: the National Surgical Adjuvant Breast and Bowel Project (NSABP), the Radiation Therapy Oncology Group (RTOG), and the Gynecologic Oncology Group (GOG).

On 16 July 2014 the German Institute for Quality and Efficiency in Health Care (IQWiG) published the results of a literature search for evidence - based clinical practice guidelines on the treatment of people with breast canceOn 16 July 2014 the German Institute for Quality and Efficiency in Health Care (IQWiG) published the results of a literature search for evidence - based clinical practice guidelines on the treatment of people with breast canceon the treatment of people with breast cancer.

«New breast cancer classification based on epigenetics.»

Based on analyses of over 600 drug and breast cancer cell pairings, researchers showed that, for some cells, drug exposure can cause significant changes in gene expression — indicating the successful action of a drug on its target — without affecting cell growth or survival.

In preliminary findings presented at the 2016 San Antonio Breast Cancer Symposium, researchers showed that older patients were as likely as younger patients to receive targeted therapy and enroll in therapeutic trials based on their sequencing results.

The probability of additional workups, and types of workups, were based on estimates from the Breast Cancer Surveillance Consortium, a collaboration of six breast imaging registries across the U.S., which contains the nation's largest collection of breast imaging informBreast Cancer Surveillance Consortium, a collaboration of six breast imaging registries across the U.S., which contains the nation's largest collection of breast imaging informbreast imaging registries across the U.S., which contains the nation's largest collection of breast imaging informbreast imaging information.

To illustrate potential mutation - specific effects on absolute cancer risks, we used the hazard ratio estimates to derive approximate absolute risks and 95 % confidence intervals, based on published estimates for the overall risks of breast and ovarian cancer by age 70 years.26 These estimates are for illustration and do not represent absolute risk estimates that would be required in a genetic counseling setting, as they do not account for noncancer outcomes that may influence a woman's life expectancy, the effects of family history, and nonrandom ascertainment of mutation carriers in this sample and depend on assumptions about the prevalence of different mutation classes in the population.

The study was based upon data from the comparison group of the Women's Healthy Eating and Living (WHEL) study — a multi-site randomized trial of the impact of a diet high in vegetables, fruits and fiber, and low in fat on the recurrence of breast cancer.

A customized treatment plan is created for each patient, based on her input and the specific prognostic factors of her breast cancer.

Given those findings, the researchers say, about 46 percent of women with breast cancer who are classified as high risk based on clinical factors might not need chemo.

These are usually personalised to the patient and are selected based on the type of breast cancer, the site and extent of spread as well as the patient's decision as to what treatments are acceptable to them.

Further research uncovered a broad spectrum of cell surface stem cell markers (e.g., CD133, CD44, and CD24) that allow the identification of CSCs in human solid tumors, including brain, breast, prostate, pancreas, liver, ovary, skin, colon cancers, and melanoma (3 - 6)(Figure 1 based on 7).

Our radiation oncologists and physicists are dedicated to ensuring that patients receive the very best radiation treatment based on their specific breast cancer diagnosis, recommended dosage, and the targeted body area receiving radiation therapy.

We will be starting with some focused studies in metastatic breast cancer and expanding over time based on what we learn from you.

«DNA - based breast cancer risk assessment has to date been focused on detecting rare mutations that confer very high risk of early onset breast cancer.

Some patients with HER2 - positive breast cancer may develop an immunosuppressive phenotype based on an increase in regulatory T cells following treatment.

This has included building programs in community - based participatory research, as well as Program - directed strategies on environmental links to, and disparities in, breast cancer.

Susan has been a member of the California Department of Health Master Plan Task Force on Breast and Cervical Cancer, the American Cancer Society Subgroup Evaluating Clinical Breast Exam, the National Quality Forum Committee on Consumer Based Measurements of Mammography Centers, and the Quality Care Advisory Board of the National Breast Cancer Coalition.

Various types of meditation have been shown to improve well - being among different populations such as physicians and the general public.14, 15, 16 Preliminary evidence suggests that meditation - based interventions may slow cellular aging rates by increasing telomerase activity, but many such studies lacked an active control group.17, 18 Recent randomized trials in breast cancer suggest that long - term intensive meditation interventions might have positive effects on telomerase activity.

Breast cancers are categorized into at least five different subgroups based on their molecular profiles.

Influence of mindfulness - based stress reduction (MBSR) on telomerase activity in women with breast cancer (BC).

Robin's research is focused on the genetic regulation of metastasis, primarily in breast cancer and is aimed at identifying new targets for molecular based therapy for patients with progressive disease.

Potential cardioprotection was based on generally supportive data on lipid levels in intermediate outcome clinical trials, trials in nonhuman primates, and a large body of observational studies suggesting a 40 % to 50 % reduction in risk among users of either estrogen alone or, less frequently, combined estrogen and progestin.2 - 5 Hip fracture was designated as a secondary outcome, supported by observational data as well as clinical trials showing benefit for bone mineral density.6, 7 Invasive breast cancer was designated as a primary adverse outcome based on observational data.3, 8 Additional clinical outcomes chosen as secondary outcomes that may plausibly be affected by hormone therapy include other cardiovascular diseases; endometrial, colorectal, and other cancers; and other fractures.3, 6,9

May 15, 2006 deCODE and Illumina Form Alliance to Develop and Commercialize DNA - based Diagnostics Companies to initiate work on molecular diagnostics for the risk of heart attack, type 2 diabetes and breast cancer Illumina to install large - scale genotyping system and...

ASHG 2017: Researchers Quantify Breast Cancer Risk Based on Rare Variants and Background Risk ASHG Press Release — October 20, 2017

«We have some new insight on why this may be and are working to develop approaches based on those theories that will lead to better immunotherapy options for all types of breast cancer,» said Lee.

I had a hunch based on this work that microRNA expression would be different in breast cancer stem cells than in more differentiated tumor cells or normal tissue and that it would change as the stem cells differentiated to form a tumor.